Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiphospholipid syndrome: an overview.

John G Hanly1

  • 1Division of Rheumatology, Department of Medicine, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS. john.hanly@cdha.nshealth.ca

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|June 25, 2003
PubMed
Summary

Antiphospholipid antibodies, linked to thrombosis and fetal loss in antiphospholipid syndrome, are crucial autoantibodies. Current therapy focuses on anticoagulation, as immunosuppression is ineffective.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Forgotten costs of systemic lupus erythematosus: estimating indirect healthcare costs in a national prospective observational Canadian lupus cohort.

Lupus science & medicine·2026
Same author

Bias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus.

Journal of clinical epidemiology·2026
Same author

Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality.

Annals of the rheumatic diseases·2025
Same author

Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring.

Arthritis & rheumatology (Hoboken, N.J.)·2025
Same author

Towards a minimal core dataset for systemic lupus erythematosus studies.

Lupus science & medicine·2025
Same author

An educational tool to improve PREeclamPsia knowledge and Aspirin adheRence in lupus prEgnancies: the PREPARE trial.

Rheumatology (Oxford, England)·2025

Area of Science:

  • Immunology
  • Hematology
  • Autoimmunity

Background:

  • Antiphospholipid antibodies (aPL) are autoantibodies targeting negatively charged phospholipids and associated proteins.
  • These antibodies are implicated in antiphospholipid syndrome (APS), characterized by thrombosis and pregnancy complications.

Purpose of the Study:

  • To elucidate the role and pathogenic mechanisms of antiphospholipid antibodies in APS.
  • To review current therapeutic strategies for APS.

Main Methods:

  • Detection of aPL using immunoassays and functional coagulation tests.
  • Review of proposed pathogenic mechanisms including coagulation interference, platelet/endothelial cell activation, and T-cell responses.

Main Results:

Related Experiment Videos

  • Antiphospholipid antibodies are etiologically significant in APS.
  • Proposed mechanisms involve complex interactions affecting hemostasis and cellular activation.

    • Conclusions:

    • Antiphospholipid antibodies play a key role in the pathogenesis of APS.
    • Anticoagulation is the primary effective treatment for APS.
    • Immunosuppressive therapies are not effective for APS.